ALAMYCIN AEROSOL 3.2 % W/V CUTANEOUS SPRAY, SOLUTION

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Principio attivo:

OXYTETRACYCLINE HYDROCHLORIDE

Commercializzato da:

Norbrook Laboratories Limited

Codice ATC:

QD06AA03

INN (Nome Internazionale):

OXYTETRACYCLINE HYDROCHLORIDE

Dosaggio:

3.2 %w/v

Forma farmaceutica:

Cutaneous Spray Solution

Tipo di ricetta:

POM

Gruppo terapeutico:

Bovine, Ovine, Porcine

Area terapeutica:

Oxytetracycline

Indicazioni terapeutiche:

Antibacterial

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

1988-10-01

Scheda tecnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Alamycin Aerosol 3.2% w/v Cutaneous Spray, solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Cutaneous Spray, solution
A blue opaque solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Alamycin Aerosol is indicated for topical use in the treatment of foot rot in sheep and topical infections caused by
organisms sensitive to oxytetracycline in cattle, sheep and pigs.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each 140g aerosol can contains:
ACTIVE SUBSTANCE
Oxytetracycline
3.2 % w/v
(as oxytetracycline hydrochloride)
EXCIPIENT
Patent Blue V (E131)
0.3 % w/v
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 15/01/2016_
_CRN 7022643_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
For external use only.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Keep away from eyes.
Use only in a well ventilated area.
Avoid inhalation and contact with skin.
Wash hands after use.
Wash any splashes immediately.
Do not spray on a naked flame or any incandescent material.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
No adverse effects or foetal abnormalities have been observed following the administration of oxytetracycline aerosol
during pregnancy and lactation.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERAC